Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 3, 2021

Total Value ($000): $557,995 (100.0% shares, 0.0% debt)

Holdings (6)

CNTA CENTESSA PHARMACEUTICALS PLC 71.3%

Value ($000) $398,090 Shares 17,923,892 Est. Cost $22.21 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 12.5%

Value ($000) $69,997 Shares 2,067,861 Est. Cost $25.13 Unrealized +42.5%

PCVX VAXCYTE INC 7.6%

Value ($000) $42,489 Shares 1,887,478 Est. Cost $32.16 Unrealized -36.3%

— MERUS N V 6.0%

Value ($000) $33,712 Shares 1,600,000 Est. Cost $14.08 Unrealized —

— CHECKMATE PHARMACEUTICALS IN 1.6%

Value ($000) $8,950 Shares 1,501,716 Est. Cost $11.51 Unrealized —

— OBSEVA SA 0.9%

Value ($000) $4,757 Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	17,923,892	$398,090	71.3%	$22.21	—	SPONSORED ADS	152309100
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$69,997	12.5%	$25.13	+42.5%	COM	71722W107
PCVX	VAXCYTE INC	1,887,478	$42,489	7.6%	$32.16	-36.3%	COM	92243G108
—	MERUS N V	1,600,000	$33,712	6.0%	$14.08	—	COM	N5749R100
—	CHECKMATE PHARMACEUTICALS IN	1,501,716	$8,950	1.6%	$11.51	—	COM	162818108
—	OBSEVA SA	1,570,000	$4,757	0.9%	$3.82	—	COM	H5861P103